moclobemide has been researched along with Recrudescence in 9 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adverse events during this long-term treatment were also compared with those of a subgroup of these patients who, before long-term treatment, were treated on a short-term basis (n = 706)." | 2.67 | Safety and efficacy during long-term treatment with moclobemide. ( Amrein, R; Moll, E; Neumann, N; Schmid-Burgk, W; Stabl, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldwin, DS | 1 |
| Green, M | 1 |
| Montgomery, SA | 2 |
| Lonnqvist, J | 1 |
| Sihvo, S | 1 |
| Syvälahti, E | 1 |
| Sintonen, H | 1 |
| Kiviruusu, O | 1 |
| Pitkanen, H | 1 |
| Moll, E | 2 |
| Neumann, N | 1 |
| Schmid-Burgk, W | 1 |
| Stabl, M | 2 |
| Amrein, R | 4 |
| Goldberg, D | 1 |
| Meienberg, O | 1 |
| Amsler, F | 1 |
| Versiani, M | 2 |
| Stein, MB | 1 |
| Nardi, AE | 1 |
| Mundim, FD | 1 |
| Alves, AB | 1 |
| Liebowitz, MR | 1 |
| Wegscheider, R | 1 |
1 review available for moclobemide and Recrudescence
| Article | Year |
|---|---|
Medication treatments for panic disorder and social phobia.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; | 1998 |
5 trials available for moclobemide and Recrudescence
| Article | Year |
|---|---|
Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
Topics: Adolescent; Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; | 2014 |
Moclobemide and fluoxetine in the prevention of relapses following acute treatment of depression.
Topics: Acute Disease; Adult; Antidepressive Agents; Benzamides; Depressive Disorder; Dose-Response Relation | 1995 |
Safety and efficacy during long-term treatment with moclobemide.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzamides; Blood Pressure; Body Weight; Depr | 1994 |
Social phobia: long-term treatment outcome and prediction of response--a moclobemide study.
Topics: Adolescent; Adult; Antidepressive Agents; Benzamides; Female; Humans; Male; Middle Aged; Moclobemide | 1997 |
Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine.
Topics: Adult; Benzamides; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; | 1992 |
3 other studies available for moclobemide and Recrudescence
| Article | Year |
|---|---|
Syndromal subgroups of depression. Workshop report.
Topics: Benzamides; Depressive Disorder; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Recurrence | 1993 |
Moclobemide in the prophylactic treatment of migraine. A retrospective analysis of 44 cases.
Topics: Analgesics; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy | 1996 |
Long-term treatment with moclobemide. An open-label, non-comparative, multiple-distributed study in patients with a major depressive episode as defined by DSM-III.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Female; Humans; Male; Middle Aged; Moclobemi | 1992 |